Transoral Incisional Fundoplication (TIF) for Patients Suffering From Gastroesophageal Reflux Disease in an Asian Population

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

Hong Kong

The Chinese University of Hong Kong, Shatin, HK, Hong Kong

Phase

Testing effectiveness

Sponsor

Chinese University of Hong Kong

Enrollment target

~20 participants

Started

August 2021

Primary completion

August 2026

Age range

18 Years – 80 Years

Last updated on clinicaltrials.gov in April 2026.

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Shannon Melissa CHAN, MBChB, FRCSEd, FHKAM (Surgery)

Chinese University of Hong Kong